This range keeps the drug stable and stops it from breaking down
Subscribe & Follow Novos expired semaglutide patent fires up weight-loss drug market The South African Health Products Regulatory Authority (SAHPRA) told Reuters that it is reviewing 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisks blockbuster diabetes and weight-loss medicines
How Serena Williams admission of using a GLP-1 drug could impact the stigma of obesity Serena Williams GLP-1 disclosure may shift obesity conversations, though treatment requires a holistic approach, Northeastern experts say
Ozempic headache is not an issue that may be classified as commonly reported
Contact your provider if you experience intractable vomiting (unable to keep down fluids for more than 24 hours), severe abdominal pain (particularly if constant or radiating to the back), or signs of dehydration including decreased urination, extreme thirst, dizziness, or confusion